Coloplast AS (COLO B):企業の財務・戦略的SWOT分析

◆英語タイトル:Coloplast AS (COLO B) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1297
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,125見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,375見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Coloplast AS (COLO B) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Coloplast A/S (Coloplast) manufactures and sells products and offers services for ostomy care, urology care, continence care, and skin and wound care. Its major products include ostomy bags; urisheaths; urine bags; catheters; anal irrigation systems; vaginal sling products; advanced foam dressings and hydrocolloid dressings for infected, non-infected and painful wounds; cleansers; moisturizers; skin protectants; anti-fungals; and hand cleansers. It also offers a wide range of disposable products to support endourological and percutaneous procedures, prostate disorders, laparoscopic procedures, and testicular prosthesis. Coloplast supplies its products through subsidiaries and distributors to hospitals, institutions, wholesalers and retailers in Europe, Asia-Pacific and North America. Coloplast is headquartered in Humlebaek, Denmark.

Coloplast AS Key Recent Developments

Mar 18,2020: Coloplast – Announcement no. 03/2020 – Revised Guidance
Mar 18,2020: Coloplast revises full-year organic growth and EBIT margin guidance for 2019/20
Feb 24,2020: Others : Coloplast A/S – Trading in Coloplast shares by board members, executives or associated persons
Feb 21,2020: Others : Coloplast A/S – Selskabsmeddelelse nr. 02/2020 – Aktietilbagekøbsprogram
Feb 21,2020: Coloplast – Announcement no. 2/2020 – share buyback programme

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Coloplast A/S – Key Facts
Coloplast A/S – Key Employees
Coloplast A/S – Key Employee Biographies
Coloplast A/S – Major Products and Services
Coloplast A/S – History
Coloplast A/S – Company Statement
Coloplast A/S – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Coloplast A/S – Business Description
Business Segment: Chronic Care
Overview
Performance
Business Segment: Interventional Urology
Overview
Performance
Business Segment: Wound & Skin Care
Overview
Performance
Geographical Segment: Emerging Markets
Performance
Geographical Segment: European Markets
Target Markets
Performance
Geographical Segment: Other Developed Markets
Performance
R&D Overview
Coloplast A/S – Corporate Strategy
Coloplast A/S – SWOT Analysis
SWOT Analysis – Overview
Coloplast A/S – Strengths
Coloplast A/S – Weaknesses
Coloplast A/S – Opportunities
Coloplast A/S – Threats
Coloplast A/S – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Coloplast A/S, Medical Equipment, Deals By Year, 2014 to YTD 2020
Coloplast A/S, Medical Equipment, Deals By Type, 2014 to YTD 2020
Coloplast A/S, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 21, 2020: Coloplast – Announcement no. 2/2020 – share buyback programme
Feb 06, 2020: Coloplast: Interim financial report, Q1 2019/20
Nov 05, 2019: Coloplast delivers a strong full-year result and the company concludes that the interventional urology business remains core to its future value creation
Nov 05, 2019: Coloplast announced its full-year financial results 2018/19
Jul 01, 2019: The French Ministry of Health has announced a price reform within Ostomy Care, Continence Care and Wound Care
May 02, 2019: Coloplast: Interim financial report, H1 2018/19
May 02, 2019: Coloplast continues solid performance in Q2 and raises expectation for reported growth in DKK
Feb 25, 2019: Coloplast awarded general urological products agreement with Premier
Feb 05, 2019: Coloplast delivers solid start to the year with 8% organic growth
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Coloplast A/S, Key Facts
Coloplast A/S, Key Employees
Coloplast A/S, Key Employee Biographies
Coloplast A/S, Major Products and Services
Coloplast A/S, History
Coloplast A/S, Other Locations
Coloplast A/S, Subsidiaries
Coloplast A/S, Key Competitors
Coloplast A/S, Ratios based on current share price
Coloplast A/S, Annual Ratios
Coloplast A/S, Annual Ratios (Cont...1)
Coloplast A/S, Annual Ratios (Cont...2)
Coloplast A/S, Interim Ratios
Coloplast A/S, Medical Equipment, Deals By Year, 2014 to YTD 2020
Coloplast A/S, Medical Equipment, Deals By Type, 2014 to YTD 2020
Coloplast A/S, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Coloplast A/S, Performance Chart (2015 - 2019)
Coloplast A/S, Ratio Charts
Coloplast A/S, Medical Equipment, Deals By Year, 2014 to YTD 2020
Coloplast A/S, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Coloplast AS (COLO B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Merck & Co., Inc.:企業のM&A・事業提携・投資動向
    Merck & Co., Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Merck & Co., Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • First Ship Lease Trust (D8DU):企業の財務・戦略的SWOT分析
    First Ship Lease Trust (D8DU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • aTyr Pharma Inc (LIFE)-製薬・医療分野:企業M&A・提携分析
    Summary aTyr Pharma Inc (aTyr Pharma) is a biotherapeutics company that discovers and develops physiocrine-based therapies. The company’s resolaris is a potential intravenous protein therapeutic for the treatment of rare myopathies with an immune component. It offers phyisiocrine, which is a class o …
  • Lanna Resources Public Company Limited:企業の戦略・SWOT・財務情報
    Lanna Resources Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Lanna Resources Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Einstein Noah Restaurant Group, Inc. (Foodservice):企業の戦略・SWOT・財務情報
    Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Shionogi & Co., Ltd.:企業のM&A・事業提携・投資動向
    Shionogi & Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shionogi & Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Calix Ltd (CXL):企業の財務・戦略的SWOT分析
    Calix Ltd (CXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • TYI 2011 Ltd:企業の戦略的SWOT分析
    TYI 2011 Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Case Western Reserve University-製薬・医療分野:企業M&A・提携分析
    Summary Case Western Reserve University (CWRU) is a private research university that offers educational and research programs. The institute provides bachelor, master’s, doctoral and research programs through its colleges and professional schools, besides postdoctoral training. It offers courses in …
  • Singapore Airlines Ltd:企業のM&A・事業提携・投資動向
    Singapore Airlines Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Singapore Airlines Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Saturn NPO:企業の戦略・SWOT・財務情報
    Saturn NPO - Strategy, SWOT and Corporate Finance Report Summary Saturn NPO - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • RS Software (India) Limited (RSSOFTWARE):企業の財務・戦略的SWOT分析
    RS Software (India) Limited (RSSOFTWARE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Engineers India Limited (ENGINERSIN):企業の財務・戦略的SWOT分析
    Engineers India Limited (ENGINERSIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • BYD Co Ltd (1211):企業の財務・戦略的SWOT分析
    BYD Co Ltd (1211) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Moberg Pharma AB (MOB):医療機器:M&Aディール及び事業提携情報
    Summary Moberg Pharma AB (Moberg Pharma), formerly Moberg Derma AB, is a pharmaceutical company. The company provides commercializes proprietary, acquired and licensed products. It provides treatment of skin diseases. Moberg Pharma treats fungal infection or psoriasis, discolored and fungus-damaged …
  • Bank of the Philippine Islands:企業の戦略・SWOT・財務情報
    Bank of the Philippine Islands - Strategy, SWOT and Corporate Finance Report Summary Bank of the Philippine Islands - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Athena Investments AS (ATHENA):電力:M&Aディール及び事業提携情報
    Summary Athena Investments AS(Athena), Previously known as Greentech Energy System A/S is an energy company which operates renewable energy plants. It generates electricity from wind and solar sources. Through long-term power purchase agreements, the company sells electricity. Athena expands its ass …
  • Global Telecom Holding SAE:企業の戦略的SWOT分析
    Global Telecom Holding SAE - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Arcato Laboratories Inc-医療機器分野:企業M&A・提携分析
    Summary Arcato Laboratories Inc (Arcato Laboratories) is an oral health company that commercializes proprietary oral care products for specialty healthcare. The company’s product includes OraWax, a medical device that is used for the treatment of irritation and oral discomfort caused from the use of …
  • Bayer AG (BAYN):製薬・医療:M&Aディール及び事業提携情報
    Summary Bayer AG (Bayer) carries out the research, development, production and commercialization of products for human and animal health care, and agriculture. It provides medicines for cardiovascular diseases, women’s health, cancer, hematology, ophthalmology and other indications. The company's pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆